DM
Deerfield Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,983,025
| Closed | -$8.72M | – | 95 |
|
|
2019
Q2 | $8.72M | Sell |
3,983,025
-1,910,391
| -32% | -$4.18M | 0.31% | 75 |
|
|
2019
Q1 | $35.3M | Hold |
5,893,416
| – | – | 1.35% | 24 |
|
|
2018
Q4 | $43.6M | Buy |
5,893,416
+2,800,000
| +91% | +$20.7M | 1.74% | 17 |
|
|
2018
Q3 | $44.9M | Buy |
3,093,416
+347,711
| +13% | +$5.05M | 1.61% | 22 |
|
|
2018
Q2 | $54.8M | Hold |
2,745,705
| – | – | 1.93% | 11 |
|
|
2018
Q1 | $48.1M | Buy |
2,745,705
+512,289
| +23% | +$8.98M | 1.67% | 14 |
|
|
2017
Q4 | $55.1M | Buy |
2,233,416
+655,489
| +42% | +$16.2M | 2.17% | 11 |
|
|
2017
Q3 | $40.7M | Buy |
1,577,927
+1,202,927
| +321% | +$31M | 1.83% | 15 |
|
|
2017
Q2 | $10.2M | Hold |
375,000
| – | – | 0.54% | 53 |
|
|
2017
Q1 | $11.2M | Hold |
375,000
| – | – | 0.43% | 60 |
|
|
2016
Q4 | $10.2M | Buy |
375,000
+259,000
| +223% | +$7.03M | 0.42% | 60 |
|
|
2016
Q3 | $2.97M | Buy |
+116,000
| New | +$2.97M | 0.14% | 72 |
|